EFSA published on 05.11.2020 the conclusion on the peer review of B.thuringiensis aizawa strain GC-91.
RoQ 05.11.2020
aluminium silicate, Bacillus thuringiensis aizawai strain GC-91, fish oil, Pythium oligandrum M1, Cydia pomonella Granulovirus (CpGV), flutolanil
RoQ 01.10.2020
Bacillus thuringiensis subsp. aizawai strain GC-91, Bacillus thuringiensis ssp aizawai strain ABTS-1857, drinking water processing guidance
RoQ 28.07.2020
Bee Guidance (new Questions), (3E) 3-decen-2-one, Bacillus thuringiensis subsp. Aizawa strain ABTS-1857, Bacillus thuringiensis subsp. Aizawa strain GC-91, prothioconazole, Gibberellic...
RoQ 02.06.2020
Regulation extension 46 substances
On 20.03.2020 Regulation 2020/421 was published, extending the approval periods of 46 substances.
SCoPAFF Legislation report 18 February published, extensions
DG SANTE published the report on the extra SCoPAFF meeting voting on the extension of 34 substances, excluding the extension of epoxiconazole.
Agenda PPR Experts’ meetings March published
EFSA published the agenda for the PPR Experts’ meetings of March 2020.
EFSA consultation Bacillus thuringiensis subsp. aizawai strain GC-91
On 02.04.2019 EFSA initiated the public consultation on the active substance Bacillus thuringiensis subsp. aizawai strain GC-91.
PAFF Legislation meeting minutes Dec. 2018 published
On 25.02.2019 DG SANTE published the minutes/report of the PAFF Legislation meeting of 12-13 December 2018.
Updated AIR 4 Working Document applicants
DG SANTE published updates of Working Document SANTE-2016-11734 in January and February.
Regulation extending approvals AIR 3.4, 3.8 and 4.1
On 05 February 2019, the extension of 42 substances was published in the Official Journal.
Commission Notice on possible Low Risk substances
On 27.07.2018 a Commission Notice was published in the Official Journal, presenting a list of potentially low risk substances. The Sustainable Use Directive (Dir. 2009/128), and more in particular...